ÀºÇòÅâÂÊ

Home Healthcare IT Prostate Cancer Treatment Market Size, Share & Growth | By 2033

Prostate Cancer Treatment Market Size, Share & Trends Analysis Report By Drug Type (Chemotherapy, Biological Therapy, Hormone Therapy, Others), By Distribution Channel (Hospitals Pharmacies, Drug Stores and Retail Pharmacies, Online Pharmacies) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRHI55383DR
Author : Debashree Bora

Table Of Content

  1. Executive Summary

    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends

    1. Global Prostate Cancer Treatment Market Introduction
    2. By Drug Type
      1. Introduction
        1. Drug Type By Value
      2. Chemotherapy
        1. By Value
      3. Biological Therapy
        1. By Value
      4. Hormone Therapy
        1. By Value
      5. Others
        1. By Value
    3. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Hospitals Pharmacies
        1. By Value
      3. Drug Stores and Retail Pharmacies
        1. By Value
      4. Online Pharmacies
        1. By Value
    1. Introduction
    2. By Drug Type
      1. Introduction
        1. Drug Type By Value
      2. Chemotherapy
        1. By Value
      3. Biological Therapy
        1. By Value
      4. Hormone Therapy
        1. By Value
      5. Others
        1. By Value
    3. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Hospitals Pharmacies
        1. By Value
      3. Drug Stores and Retail Pharmacies
        1. By Value
      4. Online Pharmacies
        1. By Value
    4. U.S.
      1. By Drug Type
        1. Introduction
          1. Drug Type By Value
        2. Chemotherapy
          1. By Value
        3. Biological Therapy
          1. By Value
        4. Hormone Therapy
          1. By Value
        5. Others
          1. By Value
      2. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Hospitals Pharmacies
          1. By Value
        3. Drug Stores and Retail Pharmacies
          1. By Value
        4. Online Pharmacies
          1. By Value
    5. Canada
    1. Introduction
    2. By Drug Type
      1. Introduction
        1. Drug Type By Value
      2. Chemotherapy
        1. By Value
      3. Biological Therapy
        1. By Value
      4. Hormone Therapy
        1. By Value
      5. Others
        1. By Value
    3. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Hospitals Pharmacies
        1. By Value
      3. Drug Stores and Retail Pharmacies
        1. By Value
      4. Online Pharmacies
        1. By Value
    4. U.K.
      1. By Drug Type
        1. Introduction
          1. Drug Type By Value
        2. Chemotherapy
          1. By Value
        3. Biological Therapy
          1. By Value
        4. Hormone Therapy
          1. By Value
        5. Others
          1. By Value
      2. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Hospitals Pharmacies
          1. By Value
        3. Drug Stores and Retail Pharmacies
          1. By Value
        4. Online Pharmacies
          1. By Value
    5. Germany
    6. France
    7. Spain
    8. Italy
    9. Russia
    10. Nordic
    11. Benelux
    12. Rest of Europe
    1. Introduction
    2. By Drug Type
      1. Introduction
        1. Drug Type By Value
      2. Chemotherapy
        1. By Value
      3. Biological Therapy
        1. By Value
      4. Hormone Therapy
        1. By Value
      5. Others
        1. By Value
    3. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Hospitals Pharmacies
        1. By Value
      3. Drug Stores and Retail Pharmacies
        1. By Value
      4. Online Pharmacies
        1. By Value
    4. China
      1. By Drug Type
        1. Introduction
          1. Drug Type By Value
        2. Chemotherapy
          1. By Value
        3. Biological Therapy
          1. By Value
        4. Hormone Therapy
          1. By Value
        5. Others
          1. By Value
      2. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Hospitals Pharmacies
          1. By Value
        3. Drug Stores and Retail Pharmacies
          1. By Value
        4. Online Pharmacies
          1. By Value
    5. Korea
    6. Japan
    7. India
    8. Australia
    9. Singapore
    10. Taiwan
    11. South East Asia
    12. Rest of Asia-Pacific
    1. Introduction
    2. By Drug Type
      1. Introduction
        1. Drug Type By Value
      2. Chemotherapy
        1. By Value
      3. Biological Therapy
        1. By Value
      4. Hormone Therapy
        1. By Value
      5. Others
        1. By Value
    3. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Hospitals Pharmacies
        1. By Value
      3. Drug Stores and Retail Pharmacies
        1. By Value
      4. Online Pharmacies
        1. By Value
    4. UAE
      1. By Drug Type
        1. Introduction
          1. Drug Type By Value
        2. Chemotherapy
          1. By Value
        3. Biological Therapy
          1. By Value
        4. Hormone Therapy
          1. By Value
        5. Others
          1. By Value
      2. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Hospitals Pharmacies
          1. By Value
        3. Drug Stores and Retail Pharmacies
          1. By Value
        4. Online Pharmacies
          1. By Value
    5. Turkey
    6. Saudi Arabia
    7. South Africa
    8. Egypt
    9. Nigeria
    10. Rest of MEA
    1. Introduction
    2. By Drug Type
      1. Introduction
        1. Drug Type By Value
      2. Chemotherapy
        1. By Value
      3. Biological Therapy
        1. By Value
      4. Hormone Therapy
        1. By Value
      5. Others
        1. By Value
    3. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Hospitals Pharmacies
        1. By Value
      3. Drug Stores and Retail Pharmacies
        1. By Value
      4. Online Pharmacies
        1. By Value
    4. Brazil
      1. By Drug Type
        1. Introduction
          1. Drug Type By Value
        2. Chemotherapy
          1. By Value
        3. Biological Therapy
          1. By Value
        4. Hormone Therapy
          1. By Value
        5. Others
          1. By Value
      2. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Hospitals Pharmacies
          1. By Value
        3. Drug Stores and Retail Pharmacies
          1. By Value
        4. Online Pharmacies
          1. By Value
    5. Mexico
    6. Argentina
    7. Chile
    8. Colombia
    9. Rest of LATAM
    1. Prostate Cancer Treatment Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Astellas Pharma Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. AstraZeneca plc
    3. Bayer AG
    4. Bristol-Myers Squibb Company
    5. F. Hoffmann-La Roche AG
    6. Ferring Pharmaceuticals Inc.
    7. GlaxoSmithKline Plc
    8. Ipsen Pharma
    9. Johnson and Johnson
    10. Takeda Pharmaceutical Company Ltd.
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
global cancer treatment market size is expected to reach USD 171,266 million in 2026 from USD 98,069 million in 2018 at a CAGR of 7.3% during the forecast period 2019–2026 Cancer is caused by uncontrolled growth of abnormal cells in distinctiv
Buy Now
Global Report
Cervical Cancer Treatment Market Size The global cervical cancer treatment market size was valued at USD 8.47 billion in 2024 and is expected to grow from USD 8.88 billion in 2025 to USD 12.91 billion by 2033, growing at a CAGR of 4.8
Buy Now
Global Report
Ear Cancer Treatment Market Size The global ear cancer treatment market size was valued at USD 1.88 billion in 2024 and, it is estimated to reach from USD 1.97 billion in 2025 to USD 2.89 billion by 2033, growing at a CAGR of 4.9% during the forecas
Buy Now
Global Report
Market Overview Global preterm labor treatment market was valued at USD 760.8 million in 2018, growing at a CAGR of 5.1% during the forecast period of (2019–2026). Preterm Labor Treatment is a medical condition resulting in uterus contraction
Buy Now
Global Report
Prostate Cancer Therapeutics Market Size The global prostate cancer therapeutics market size was valued at USD 13.21 billion in 2024 and is estimated to grow from USD 14.33 billion in 2025 to reach USD 27.55 billion by 2033, growing a
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report


We are featured on :